Our Pricing

Promethazine BNF Quick Reference UK

This promethazine BNF quick reference UK guide provides essential dosing, safety, and prescribing information for promethazine hydrochloride (Phenergan). At Cured Pharmacy, you can access genuine UK-licensed Phenergan tablets and elixir from £17.54, with free clinical consultation and discreet next-day delivery across the UK.

Promethazine Hydrochloride: BNF Classification and Indications

Promethazine hydrochloride is classified in the BNF under antihistamines (sedating) and is licensed in the UK for allergic conditions, motion sickness, nausea and vomiting, and short-term insomnia [1]. As a first-generation antihistamine, promethazine crosses the blood-brain barrier, producing both peripheral H1-receptor antagonism and central sedative effects that distinguish it from newer non-sedating alternatives.

The MHRA licenses Phenergan tablets (25mg) and Phenergan Elixir (5mg/5ml) for adults and children over specific age thresholds [2]. Clinical indications include symptomatic relief of allergic rhinitis, urticaria, pruritus, prevention and treatment of motion sickness, management of nausea and vomiting (including post-operative), and short-term management of insomnia associated with anxiety.

BNF Dosing Guidelines for Promethazine

Adult dosing varies by indication according to BNF guidance. For allergic conditions, the typical dose is 25mg at night, increased to 25mg twice daily if necessary, with a maximum of 100mg daily in divided doses [1]. Motion sickness prevention requires 25mg taken the night before travel, then 25mg on the morning of travel, repeated after 6-8 hours if needed.

For nausea and vomiting, adults may take 25mg initially, followed by 12.5-25mg every 4-6 hours as required. When used for short-term insomnia, the recommended dose is 25-50mg at night [2]. Elderly patients should start at the lower end of the dosing range due to increased sensitivity to anticholinergic and sedative effects.

Paediatric Dosing Considerations

Children aged 5-10 years may receive 12.5-25mg depending on indication, whilst those aged 10 years and over can take adult doses under medical supervision [1]. Promethazine is contraindicated in children under 2 years due to risk of fatal respiratory depression, and should be used with caution in children aged 2-5 years only under specialist advice [2]. The elixir formulation allows flexible dosing for younger patients when clinically appropriate.

Contraindications and Cautions from BNF

Absolute contraindications include hypersensitivity to promethazine or other phenothiazines, children under 2 years of age, and concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation [3]. Promethazine should not be used in patients with severe coronary artery disease, acute porphyria, or those in a comatose state.

The BNF advises caution in elderly patients, those with prostatic hypertrophy, urinary retention, glaucoma (particularly angle-closure), epilepsy, hepatic impairment, and severe renal impairment [3]. Patients with respiratory conditions including asthma and chronic obstructive pulmonary disease require careful monitoring due to promethazine's anticholinergic effects on bronchial secretions. Alcohol should be avoided during treatment as it potentiates central nervous system depression.

Common and Serious Side Effects

The most frequently reported side effect is drowsiness, affecting a significant proportion of patients, particularly during initial treatment [4]. Other common anticholinergic effects include dry mouth, blurred vision, urinary retention, and constipation. These effects typically diminish with continued use but may persist in elderly patients.

Serious adverse reactions, though rare, include blood dyscrasias (agranulocytosis, thrombocytopenia), paradoxical central nervous system stimulation in children, severe hypotension, and extrapyramidal effects [4]. Photosensitivity reactions can occur, and patients should be advised to use sun protection. The MHRA has issued specific warnings regarding respiratory depression in children, emphasising the importance of age-appropriate dosing and contraindications in very young children [2].

Managing Side Effects in Clinical Practice

Patients experiencing excessive sedation should be advised to take promethazine at bedtime when treating daytime allergic symptoms, or to consider non-sedating antihistamine alternatives for conditions not requiring sedation. Anticholinergic effects may be minimised by ensuring adequate hydration and using sugar-free gum for dry mouth. Any signs of blood disorders, jaundice, or movement disorders require immediate medical review and treatment discontinuation.

Drug Interactions and Monitoring Requirements

Promethazine exhibits significant pharmacokinetic and pharmacodynamic interactions with multiple drug classes. Concurrent use with other CNS depressants including benzodiazepines, opioids, alcohol, and barbiturates produces additive sedation and respiratory depression [3]. MAOIs potentiate and prolong the anticholinergic and sedative effects of promethazine, creating a potentially dangerous combination.

Anticholinergic drugs used concurrently (including tricyclic antidepressants, antimuscarinics for urinary incontinence, and antiparkinson agents) increase the risk of antimuscarinic side effects such as confusion, urinary retention, and constipation, particularly in elderly patients [3]. Promethazine may interfere with allergy skin testing by suppressing wheal and flare reactions, so should be discontinued at least 72 hours before testing. Blood pressure monitoring is advisable when initiating treatment in patients with cardiovascular conditions or those taking antihypertensive medications.

Prescribing Promethazine: Clinical Decision-Making

When considering promethazine therapy, UK prescribers must weigh the benefits of its multi-indication efficacy against the sedation profile and anticholinergic burden. For allergic conditions in patients requiring daytime alertness, non-sedating antihistamines like cetirizine or loratadine represent first-line choices, reserving promethazine for evening dosing or breakthrough symptoms [1].

Promethazine's unique position as both an antihistamine and antiemetic makes it particularly valuable for motion sickness prophylaxis and nausea management where sedation is acceptable or even desirable. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team assess each patient's individual circumstances, comorbidities, and concurrent medications during the online consultation to ensure promethazine is clinically appropriate and safe. All prescriptions are issued only after thorough clinical assessment by UK-registered prescribers in accordance with MHRA and GPhC guidelines.

When to Choose Phenergan Tablets vs Elixir

Phenergan 25mg tablets suit adults and children over 10 years requiring standard dosing for allergies, motion sickness, or insomnia. The elixir formulation (5mg/5ml) provides dosing flexibility for children aged 5-10 years and patients with swallowing difficulties, allowing precise titration to the lowest effective dose. Both formulations contain the same active ingredient and demonstrate equivalent bioavailability, so the choice depends on patient age, preference, and dosing requirements [1].

Scientific References

1. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. BMJ Group and Pharmaceutical Press. https://bnf.nice.org.uk/drug/promethazine-hydrochloride.html
2. Medicines and Healthcare products Regulatory Agency. (2019). Promethazine for allergy: new pack size restrictions for oral preparations. Drug Safety Update, 12(10), 3. https://www.gov.uk/drug-safety-update/promethazine-for-allergy
3. Electronic Medicines Compendium. (2023). Phenergan 25mg Tablets - Summary of Product Characteristics. Datapharm Ltd. https://www.medicines.org.uk/emc/product/909
4. Simons, F. E. R., & Simons, K. J. (2011). Histamine and H1-antihistamines: celebrating a century of progress. Journal of Allergy and Clinical Immunology, 128(6), 1139-1150. https://doi.org/10.1016/j.jaci.2011.09.005

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.